PODD
INSULET CORPPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 25 ▲ 1 insider buy $499.8K at $246.23
- May 15 to May 27 ▼ 2 sells: Ro Khanna sold $1,001 - $15,000, last disclosed Jun 11
- Jun 3 ▼ 1 insider sell $59.9K at $143.27
- Jun 3 ▲ 2 insiders buy $897.9K at $143.89
- Jun 30 ▲ 3 funds open new positions (13F)
- Aug 6 ▼ 5 downgrades
- Aug 21 ▲ 1 insider buy $162.2K at $147.47
- Sep 4 to Sep 25 ▼ 3 sells: Ro Khanna, Gilbert Cisneros sold $1,001 - $15,000, last disclosed Oct 13
- Sep 21 ▲ Insulet Corporation entered into a Ninth Amendment to its Credit Agr…
- Oct 20 ▲ Gilbert Cisneros bought $1,001 - $15,000, last disclosed Nov 11
- Nov 4 ▲ Insulet reported Q3 2026 revenue of $842.0M (+19.2% YoY, +19.6% cons…
- Nov 4 ▲ Earnings: PODD Q3 2026 Earnings: EPS $1.99 (+22.9% vs est)
Signal stack
Where each data set points today.
- InsidersBULLISH
4 insiders bought $1.6M at an average $166.48. 1 insider sold $59.9K. Price is 12% below their cost.
- InstitutionsMIXED
Q2 2026: 75 added (3 new), 52 trimmed or exited. Largest new: Tudor Investment Et Al $21.3M, Alta Fox Capital Management $12.6M.
- AnalystsBULLISH
19 of 32 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −5.4% to 5.33M shares. 4.3 days to cover, ≈7.7% of shares.
- TrendUPTREND
3% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| MORGAN STANLEY | ADD | $225.2M |
| JUPITER ASSET MANAGEMENT LTD | ADD | $156.3M |
| FMR LLC | NEAR_EXIT | $146.8M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | $131.8M |
| CITADEL ADVISORS LLC | DOUBLED | $121.3M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | DOUBLED | $94.8M |
| JPMORGAN CHASE & CO | DOUBLED | $94.4M |
| DIMENSIONAL FUND ADVISORS LP | ADD | $83.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
32 analystsPrice is below the lowest target. Median implies +24%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | Truist Securities REITERATE | Hold |
| Nov 6, 2026 | Barclays MAINTAIN | Equal-Weight |
| Nov 5, 2026 | UBS MAINTAIN | Neutral |
| Nov 5, 2026 | JP Morgan MAINTAIN | Neutral |
| Nov 5, 2026 | Citigroup MAINTAIN | Neutral |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Market Perform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Pease Flavia EVP & CFO Oct 1, 2026 | TAX W/H | $246.1K |
MAZELSKY JONATHAN JAY Director Sep 30, 2026 | AWARD | $18.4K |
Huffines Robert Luther Director Sep 30, 2026 | AWARD | $23.2K |
McEvoy Ashley President and CEO Aug 21, 2026 | BUY | $162.2K |
Davis Lisa Blair SVP, Chief HR Officer Aug 1, 2026 | TAX W/H | $40.3K |
MAZELSKY JONATHAN JAY Director Jul 1, 2026 | AWARD | 1,355 sh |
Huffines Robert Luther Director Jun 30, 2026 | AWARD | $23.0K |
Huffines Robert Luther Director Jun 30, 2026 | AWARD | $23.0K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
10 filings · 3 bullish · 2 bearish · 1 mixed · 4 neutral- NEUTRAL SC 13GNov 13, 2026
AQR Capital Management LLC filed a new Schedule 13G disclosing a 6.85% passive stake in Insulet…
AQR's entry as a new 5%+ holder adds a quantitatively-driven investor to the register. Monitor future 13F filings for position sizing and any subsequent 13G amendments for stake changes. No activist…
- BULLISH 8-KNov 4, 2026
Insulet reported Q3 2026 revenue of $842.0M (+19.2% YoY, +19.6% constant currency), slightly above…
The raised full-year guidance and $1B buyback signal management confidence in sustained growth and margin expansion. Monitor Q4 execution on the type 2 diabetes action plan and Omnipod 5/Discover…
- NEUTRAL SC 13G/AOct 27, 2026
BlackRock Inc. filed an amended Schedule 13G reporting a 7.7% passive stake in Insulet Corp as of…
Monitor for any future conversion to a Schedule 13D, which would signal a shift to activist intent. The increase in BlackRock's stake is routine for a passive index/asset manager and does not…
- NEUTRAL INST-CLUSTEROct 23, 2026
Institutional activity in PODD during Q3 2026 shows a mixed picture: 4 buyers added $39M in new…
The divergence between Assenagon's aggressive accumulation and Robeco's near-total exit suggests institutional disagreement on PODD's near-term outlook. Monitor upcoming earnings for fundamental…
All PODD filing & press-release reports (10)
- SC 13G reportNov 13, 2026
- 8-K reportNov 4, 2026
- SC 13G/A reportOct 27, 2026
- INST-CLUSTER reportOct 23, 2026
- 8-K reportSep 21, 2026
- 8-K reportAug 5, 2026
- INST-CLUSTER reportJul 24, 2026
- COURT-RULING reportMay 28, 2026
- 8-K reportMay 6, 2026
- 8-K reportMar 4, 2026